New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?

Nanomedicine - Tập 1 Số 3 - Trang 297-309 - 2006
Si‐Shen Feng1
1Nanoscience & Nanoengineering Initiative (NUSNNI), Department of Chemical & Biomolecular Engineering and Division of Bioengineering, Faculty of Engineering, National University of Singapore, Block E5, 02–11, 4 Engineering Drive, 117576Singapore.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1586/14737140.3.5.579

10.1586/17434440.1.1.115

10.1016/S0009-2509(03)00234-3

Ehrlich P : Chemotherapeutics: scientific principles, methods and results.LancetII, 445–451 (1913).

10.1021/ar9800993

10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F

10.1560/ATQM-MQ02-GLDU-EF6L

10.1016/S0168-3659(00)00339-4

10.3390/10010146

Kumar MNVR : Nano and microparticles as controlled drug delivery devices.J. Pharm. Sci.3(2), 234–258 (2000).

10.1126/science.310.5751.1132

Ferrari M : Cancer nanotechnology: opportunities and challenges.Nature5, 161–171 (2005).

10.1096/fj.04-2747rev

10.1016/j.biomaterials.2005.11.008

10.1016/S0168-3659(02)00025-1

10.1016/j.biomaterials.2004.07.050

10.1016/j.biomaterials.2005.05.104

10.1016/j.biomaterials.2006.03.006

10.1021/bm050953v

10.1016/j.biomaterials.2003.09.055

10.1002/jbm.a.30684

10.1016/j.biomaterials.2005.03.021

10.2174/0929867043455909

10.1023/B:PHAM.0000003387.15428.42

10.1016/S0168-3659(02)00320-6

10.1016/S0928-4931(02)00017-6

10.1016/S0168-3659(00)00364-3

10.1016/j.jconrel.2004.12.023

10.1016/S0168-3659(01)00440-0

10.1023/B:PHAM.0000016249.52831.a5

10.1002/jps.10507

10.1016/S0142-9612(02)00440-4

10.1023/A:1019854327540

10.1023/A:1015393710253

10.1016/S0939-6411(00)00084-9

Qaddoumi MG , UedaH, YangJet al.: The mechanism of uptake of biodegradable PLGA nanoparticles in conjunctival epithelial cell layers.Invest. Ophthalmol. Vis. Sci.42, 2628 (2001).

10.1016/S0168-3659(02)00212-2

10.1007/s10856-006-8933-3

10.1016/j.ijpharm.2004.10.009

10.1080/10717540490467384

10.1248/cpb.49.1444

10.1038/bjc.1993.488

10.1007/s11095-005-4590-3

10.1016/S0168-3659(00)00280-7

10.1016/S0168-3659(01)00306-6

10.1016/S0168-3659(01)00488-6

10.1016/S0168-3659(01)00308-X

10.1166/jnn.2005.219

10.1016/j.jconrel.2005.08.013

10.1021/cm052067x

10.1016/j.jmmm.2005.02.061

10.1126/science.1095833

10.1016/j.copbio.2005.10.009

10.1006/bbrc.1999.0177

10.1016/S0167-4889(02)00256-2

10.1158/0008-5472.CAN-05-4076

10.1038/ncponc0509

10.2165/00003495-200666040-00005

Rodolfo M , MelaniC, ZilocchiCet al.: IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases. Cancer Res.58, 5812–6817 (1998).

10.1016/S0168-3659(03)00215-3

10.1158/0008-5472.CAN-04-3921

10.1016/j.nuclcard.2004.09.002

10.1016/j.copbio.2004.11.003

10.1038/nbt994

Shin JH , ChungnJK, KangJH: Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene.J. Nucl. Med.45, 2109–2115 (2004).

10.1126/science.1088755

US National Institute of Health www.nih.gov

US National Cancer Institute Nanotechnology in Cancer Alliance http://nano.cancer.gov/ resource_center/sci_biblio_enabled-therapeutics.asp

Nanomedicine Research Portal www.nano-biology.net/showcitationlist. php?sort=citations& keyword=e